When was Cerveau Technologies founded?

Cerveau Technologies was founded in 2015.

Where is Cerveau Technologies located?

Cerveau Technologies is headquartered in Boston, United States.

How many employees does Cerveau Technologies have?

As of Jun 30, 2026, the latest employee count at Cerveau Technologies is 1281.

Where does Cerveau Technologies rank among its competitors?

Cerveau Technologies ranks 8th amongst 209 active competitors, of which 5 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was PharmAla Biotech, which secured $1.09M in Dec, 2024.

Who are the top competitors of Cerveau Technologies?

Cerveau Technologies' top competitors include Vasta Global, PharmAla Biotech and S-Cubed. Among them, PharmAla Biotech secured the most recent funding round in December, 2024.

Cerveau Technologies - 2026 Company Profile & Competitors

Company Details

Innovating PET imaging agents for Alzheimer's disease research and diagnostics, focusing on developing and providing novel PET imaging agents, specifically for tau in Alzheimer's disease. They manage all aspects of production, supply chain, and data analytics to ensure seamless incorporation of their imaging biomarker. The company offers technical operations expertise, a global GMP production and distribution network, regulatory compliance support, and customer support. They partner with researchers in academia and the pharmaceutical industry to advance Alzheimer's research, offering opportunities for collaboration and access to their investigational tau PET imaging agent as a preferred biomarker in AD studies. Their mission is to improve patient outcomes through innovative diagnostic solutions.

Website: cerveautechnologies.com
Social

Key Metrics

Founded Year

2015

Location

Boston, United States

Stage

Acquired

Ranked

8^th among 209 active competitors

Employee Count

1,281 as on Jun 30, 2026

Similar Companies

Vasta Global & 250 more

Exit Details

Acquired by Lantheus (Feb 06, 2023)

View Cerveau Technologies' full profile

Cerveau Technologies got acquired by Lantheus on Feb 06, 2023.

Click here to take a look at Cerveau Technologies's acquisition in detail

Cerveau Technologies has not raised any funding rounds yet.

Cerveau Technologies' employee count trend

Cerveau Technologies has 1,281 employees as of Jun 26. Here is Cerveau Technologies's employee count trend over the years:

Employee count trend for Cerveau Technologies

Uncover Cerveau Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cerveau Technologies include Vasta Global, PharmAla Biotech and S-Cubed. Here is the list of Top 10 competitors of Cerveau Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Vasta Global 2010, Mumbai (India), Acquired	Offers clinical research consulting	-	-	57/100
2nd	PharmAla Biotech 2021, Toronto (Canada), Public	Provider of biomanufacturing, regulatory, and financial services	-	-	43/100
3rd	S-Cubed 2007, Copenhagen (Denmark), Acquired	Clinical development consultancy services in areas such as biometrics, CDISC, and regulatory affairs	-	-	42/100
4th	Pharmefex 2014, Bellevue (United States), Unfunded	CMC consulting for biologics, cell, and gene therapies	-	-	42/100
5th	Biomapas 2001, Kaunas (Lithuania), Acquired	Manufacturer of clinical research for medical devices	-	Carbyne Equity Partners	40/100
6th	Blue Matter Consulting 2012, San Francisco (United States), Late Stage	Provider of consulting services focused for clinical drug development	-	Baird Capital	38/100
7th	TransCelerate BioPharma 2012, Conshohocken (United States), Unfunded	Provider of clinical development consulting services	-	-	38/100
8th	Cerveau Technologies 2015, Boston (United States), Acquired	Innovating PET imaging agents for Alzheimer's disease research and diagnostics	-	-	36/100
9th	Orchestra Life Sciences 2021, Chesterfield (United States), Unfunded	Provider of technical consultancy for cancer and rare disease therapies	-	-	36/100
10th	MCRA 2004, New York City (United States), Funding Raised	Provider of regulatory, quality assurance and market access services to biopharma sector	-	Caltius Capital Management, Viscogliosi Brothers	35/100